Search This Blog

Friday, October 18, 2019

FDA OKs Teligent gentamicin cream; shares up 14%

The FDA approves Teligent’s (TLGT +13.7%) Gentamicin Sulfate Cream USP, 0.1%.
Per IQVIA, the U.S. market is ~$15.6M.
https://seekingalpha.com/news/3507037-fda-oks-teligent-gentamicin-cream-shares-14-percent

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.